Retrospective Cohort Study of Novel Oral Agents Lenalidomide and Duvelisib For Relapsed or Refractory Mycosis Fungoides and Sézary Syndrome

Published: 12 November 2024| Version 1 | DOI: 10.17632/nh69skddb7.1
Contributor:
Omar Elghawy

Description

Supplemental Figure for Manuscript

Files

Categories

Dermatology, Lymphoma, Cutaneous T-Cell Lymphoma, Mycosis Fungoides

Licence